COMPARISON OF TWO CHEMOTHERAPY REGIMENS (AI VS. EIA) COMBINED WITH REGIONAL HYPERTHERMIA (RHT) IN HIGH-RISK SOFT-TISSUE SARCOMA (HR-STS)

被引：0
|
作者：
Aubele, P. O. [1 ]
Kampmann, E. [1 ]
Schuebbe, G. [1 ]
Abdel-Rahman, S. [1 ]
Dieterle, N. [1 ]
Laubender, R. [2 ]
Issels, R. [3 ]
Lindner, L. [1 ]
机构：
[1] Univ Hosp Munich Grosshadern, Dept Internal Med Hematol Oncol 3, Munich, Germany
[2] Univ Munich, Inst Med Informat Biostat & Epidemiol, Munich, Germany
[3] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Neuherberg, Germany
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：487 / 487
页数：1
相关论文
共 50 条
  • [31] Pathological grade of tumorregression after neoadjuvant chemotherapy with doxorubicin/ifosfamid and regional hyperthermia correlates with survival outcomes in patients with high-risk soft tissue sarcoma
    Schuebbe, G-E.
    Knoesel, T.
    Duerr, H. R.
    Angele, M.
    Roeder, F.
    Abdel-Rahman, S.
    Alig, A.
    Issels, R. D.
    Di Gioia, D.
    Lindner, L. H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Morphological grade of regression after neoadjuvant chemotherapy with doxorubicin/ifosfamide and regional hyperthermia as predictive marker for survival in patients with high-risk soft tissue sarcoma
    Schuebbe, G. -E.
    Knoesel, T.
    Duerr, H. R.
    Angele, M.
    Roeder, F.
    Abdel-Rahman, S.
    Alig, A.
    Di Gioia, D.
    Lindner, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 111 - 111
  • [33] Histopathological response (HR) after neoadjuvant chemotherapy (ChT) for high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 trial
    Pasquali, Sandro
    Collini, Paola
    Romagosa, Cleofe
    Coindre, Jean Michel
    Pizzamiglio, Sara
    Verderio, Paolo
    Barisella, Marta
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Lopez-Pousa, Antonio
    Grignani, Giovanni
    Blay, Jean-Yves
    Lugowska, Iwona A.
    Fontana, Valeria
    Sbaraglia, Marta
    Bague, Silvia
    De Tos, Paolo
    Casali, Paolo G.
    Gronchi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma
    Thomas Schmitt
    Burkhard Lehner
    Bernd Kasper
    Marc Bischof
    Falk Roeder
    Sascha Dietrich
    Antonia Dimitrakopoulou-Strauss
    Ludwig G Strauss
    Gunhild Mechtersheimer
    Patrick Wuchter
    Anthony D Ho
    Gerlinde Egerer
    BMC Cancer, 11
  • [35] A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma
    Schmitt, Thomas
    Lehner, Burkhard
    Kasper, Bernd
    Bischof, Marc
    Roeder, Falk
    Dietrich, Sascha
    Dimitrakopoulou-Strauss, Antonia
    Strauss, Ludwig G.
    Mechtersheimer, Gunhild
    Wuchter, Patrick
    Ho, Anthony D.
    Egerer, Gerlinde
    BMC CANCER, 2011, 11
  • [36] Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities
    Vanzulli, Andrea
    Vigorito, Raffaella
    Buonomenna, Ciriaco
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Pousa, Antonio Lopez
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Diaz-Beveridge, Robert
    Ferraresi, Virginia
    Lugowska, Iwona A.
    Pizzamiglio, Sara
    Verderio, Paolo
    Duroni, Valeria
    Fontana, Valeria
    Morosi, Carlo
    Stacchiotti, Silvia
    Gronchi, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study
    Frezza, Anna Maria
    Stacchiotti, Silvia
    Chibon, Frederic
    Coindre, Jean-Michelle
    Italiano, Antoine
    Romagnosa, Cleofe
    Bague, Silvia
    Dei Tos, Angelo Paolo
    Braglia, Luca
    Palmerini, Emanuela
    Quagliuolo, Vittorio
    Broto, Javier Martin
    Pousa, Antonio Lopez
    Grignani, Giovanni
    Brunello, Antonella
    Blay, Jean-Yves
    Beveridge, Robert Diaz
    Lugowska, Iwona
    Lesluyes, Tom
    Maestro, Roberta
    Merlo, Franco Domenico
    Casali, Paolo Giovanni
    Gronchi, Alessandro
    CANCER MEDICINE, 2023, 12 (02): : 1350 - 1357
  • [38] Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas
    Wendtner, CM
    Abdel-Rahman, S
    Krych, M
    Baumert, J
    Lindner, LH
    Baur, A
    Hiddemann, W
    Issels, RD
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) : 3156 - 3164
  • [39] Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: A phase III randomised pros
    Issels, R. D.
    Lindner, L. H.
    Wust, P.
    Hohenberger, P.
    Jauch, K.
    Daugaard, S.
    Mansmann, U.
    Hiddemann, W.
    Blay, J.
    Verweij, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial
    Vanzulli, A.
    Vigorito, R.
    Buonomenna, C.
    Palmerini, E.
    Quagliuolo, V.
    Broto, J. M.
    Pousa, A. Lopez
    Grignani, G.
    Brunello, A.
    Blay, J. -y.
    Beveridge, R. Diaz
    Ferraresi, V.
    Lugowska, I.
    Pizzamiglio, S.
    Verderio, P.
    Duroni, V.
    Fontana, V.
    Donati, D. M.
    Palassini, E.
    Bianchi, G.
    Bertuzzi, A.
    Buonadonna, A.
    Pasquali, S.
    Tos, A. P. Dei
    Casali, P. G.
    Morosi, C.
    Stacchiotti, S.
    Gronchi, A.
    ESMO OPEN, 2025, 10 (03)
12345